![CME Programme CSHK mw_menu_data_5564_56eb2b174e5e3.jpg](https://cshk.org/site/CSHK/upload/mw_menu_data/file/mw_menu_data_5564_56eb2b174e5e3.jpg)
CME Programme
-
Non-Regular Activities
CMCDA Clinical Meeting - An new ear of PsA management with Guselkumab, an IL-23 inhibitorDate: 18/11/2022 Enquiries: Caritas Medical Centre Doctors' Association CME Points Awarded: 1 point